Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.49% | -217.72% | -510.81% | -416.66% | -290.08% |
| Total Depreciation and Amortization | 92.52% | 252.51% | 2,971.91% | 1,833.33% | 1,035.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,074.45% | 572.14% | 351.77% | 144.78% | -57.09% |
| Change in Net Operating Assets | -1,619.41% | -1,619.41% | -1,619.41% | -436.01% | 127.33% |
| Cash from Operations | -117.94% | -250.82% | -849.89% | -510.50% | -242.14% |
| Capital Expenditure | -13.88% | -66.81% | -148.51% | -194.57% | -333.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.83% | 94.50% | 95.69% | 86.37% | 76.45% |
| Cash from Investing | 84.61% | 92.43% | 94.15% | 85.14% | 75.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -447.08% | -759.74% | -- | -684.57% | -90.12% |
| Issuance of Common Stock | -45.16% | -53.70% | -59.88% | -18.57% | 89.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.90% | 9.55% | 42.53% | 5.82% | -90.54% |
| Cash from Financing | -12.70% | -24.83% | -33.66% | 0.09% | 89.45% |
| Foreign Exchange rate Adjustments | -173.79% | -172.00% | -163.83% | 23.35% | 106.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.60% | -132.34% | -121.84% | -81.11% | 213.31% |